|
Friday 27th May 2022 |
Text too small? |
- the Company completed a 100 to 1 share consolidation in November 2021. As result of the consolidation, and after taking account of rounding of entitlements, the number of shares on issue in Ascension reduced from 1,914,888,105 to 19,148,828.
- there were no changes in the board of directors.
The focus of the Board going forward is to identify a suitable business opportunity to invest in and/or acquire through a reverse takeover transaction. Currently, there are no initiatives being investigated, but the Company will provide the market with any updates as to material developments in due course.
The financial result for the Company for the year ended 31 March 2022 is a loss after taxation of NZ$171,171, which is largely made up of the directors’ fees, NZX listing costs, and legal and accounting costs.
No comments yet
RYM - Ryman Healthcare appoints new independent director
ikeGPS 4Q FY26 and Full Year FY26 Performance Update
HGH - Heartland trading update
CVT - Comvita Rights Offer Opens
GNE - FY26 Q3 Performance Report and Updated Guidance
April 23rd Morning Report
Devon Funds Morning Note - 22 April 2026
AGL - Accordant Group Limited announces opening of Rights Offer
April 22nd Morning Report
BPG - Q4 FY26 Update: ARR reaches $26.8m